Tricida, Inc. Insider Trading for March 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Tricida, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Tricida, Inc. for March 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 29 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Option Exercise | M | 0.80 | 22,100 | 17,680 | 11,900 | |
Mar 29 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 34.18 | 22,100 | 755,378 | 63,344 | 85.4 K to 63.3 K (-25.86 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 34.19 | 22,100 | 755,599 | 63,344 | 85.4 K to 63.3 K (-25.86 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 34.19 | 22,100 | 755,599 | 39,436 | 61.5 K to 39.4 K (-35.91 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Buy | M | 0.80 | 22,100 | 17,680 | 61,536 | 39.4 K to 61.5 K (+56.04 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Option Exercise | M | 0.72 | 6,000 | 4,320 | 14,100 | |
Mar 29 2019 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Sell | S | 29.99 | 6,000 | 179,940 | 13,832 | 19.8 K to 13.8 K (-30.25 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | Stahl Wilhelm | Chief Tech Officer ... | Buy | M | 0.72 | 6,000 | 4,320 | 19,832 | 13.8 K to 19.8 K (+43.38 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 7,438 | 5,950 | 5,124 | |
Mar 29 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 8,062 | 6,450 | 0 | |
Mar 29 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 30.74 | 15,500 | 476,470 | 0 | 15.5 K to 0 (-100.00 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 7,438 | 5,950 | 15,500 | 8.1 K to 15.5 K (+92.26 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 8,062 | 6,450 | 8,062 | 0 to 8.1 K |
Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 1.68 | 27,856 | 46,798 | 23,576 | |
Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 1.68 | 13,919 | 23,384 | 9,950 | |
Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 2.39 | 8,165 | 19,514 | 21,985 | |
Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 2,985 | 2,388 | 100,307 | |
Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 35.00 | 52,925 | 1,852,375 | 0 | 52.9 K to 0 (-100.00 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 1.68 | 27,856 | 46,798 | 52,925 | 25.1 K to 52.9 K (+111.12 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 1.68 | 13,919 | 23,384 | 25,069 | 11.2 K to 25.1 K (+124.83 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 2.39 | 8,165 | 19,514 | 11,150 | 3 K to 11.2 K (+273.53 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 2,985 | 2,388 | 2,985 | 0 to 3 K |
Mar 29 2019 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 32.49 | 26,400 | 857,736 | 114,584 | 141 K to 114.6 K (-18.73 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | KLAERNER GERRIT | President and CEO | Sell | S | 33.36 | 31,422 | 1,048,238 | 668,840 | 700.3 K to 668.8 K (-4.49 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 26.70 | 2,000 | 53,400 | 15,725 | 17.7 K to 15.7 K (-11.28 %) |
Mar 29 2019 | TCDA | Tricida, Inc. | Alpern Robert J | Director | Sell | S | 33.63 | 14,000 | 470,820 | 165,511 | 179.5 K to 165.5 K (-7.80 %) |
Mar 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Option Exercise | M | 0.80 | 4,000 | 3,200 | 34,000 | |
Mar 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 23.80 | 4,000 | 95,200 | 85,444 | 89.4 K to 85.4 K (-4.47 %) |
Mar 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 23.84 | 4,000 | 95,360 | 85,444 | 89.4 K to 85.4 K (-4.47 %) |
Mar 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Sell | S | 23.85 | 4,000 | 95,400 | 39,436 | 43.4 K to 39.4 K (-9.21 %) |
Mar 28 2019 | TCDA | Tricida, Inc. | VEITINGER KLAUS R DR | Director | Buy | M | 0.80 | 4,000 | 3,200 | 43,436 | 39.4 K to 43.4 K (+10.14 %) |
Mar 19 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 1,729 | 1,383 | 8,062 | |
Mar 19 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 771 | 617 | 9,791 | |
Mar 19 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 25.02 | 1,729 | 43,260 | 0 | 1.7 K to 0 (-100.00 %) |
Mar 19 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 1,729 | 1,383 | 1,729 | 0 to 1.7 K |
Mar 19 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 25.02 | 771 | 19,290 | 0 | 771 to 0 (-100.00 %) |
Mar 19 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 771 | 617 | 771 | 0 to 771 |
Mar 19 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 14,681 | 11,745 | 103,292 | |
Mar 19 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 1,825 | 1,460 | 117,973 | |
Mar 19 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 25.23 | 14,681 | 370,402 | 0 | 14.7 K to 0 (-100.00 %) |
Mar 19 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 14,681 | 11,745 | 14,681 | 0 to 14.7 K |
Mar 19 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 25.02 | 1,825 | 45,662 | 0 | 1.8 K to 0 (-100.00 %) |
Mar 19 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 1,825 | 1,460 | 1,825 | 0 to 1.8 K |
Mar 15 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 2,000 | 1,600 | 10,562 | |
Mar 15 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Option Exercise | M | 0.80 | 2,000 | 1,600 | 10,562 | |
Mar 15 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 25.00 | 2,000 | 50,000 | 0 | 2 K to 0 (-100.00 %) |
Mar 15 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Sell | S | 25.00 | 2,000 | 50,000 | 0 | 2 K to 0 (-100.00 %) |
Mar 15 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 2,000 | 1,600 | 2,000 | 0 to 2 K |
Mar 15 2019 | TCDA | Tricida, Inc. | Otto Dawn Parsell | Sr VP, Clinical Dev ... | Buy | M | 0.80 | 2,000 | 1,600 | 2,000 | 0 to 2 K |
Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 1,508 | 1,206 | 119,798 | |
Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 1,508 | 1,206 | 119,798 | |
Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 11,986 | 9,589 | 121,306 | |
Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Option Exercise | M | 0.80 | 11,986 | 9,589 | 121,306 | |
Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 25.02 | 1,508 | 37,730 | 0 | 1.5 K to 0 (-100.00 %) |
Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 25.02 | 1,508 | 37,730 | 0 | 1.5 K to 0 (-100.00 %) |
Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 1,508 | 1,206 | 1,508 | 0 to 1.5 K |
Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 1,508 | 1,206 | 1,508 | 0 to 1.5 K |
Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 25.01 | 11,986 | 299,770 | 0 | 12 K to 0 (-100.00 %) |
Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Sell | S | 25.01 | 11,986 | 299,770 | 0 | 12 K to 0 (-100.00 %) |
Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 11,986 | 9,589 | 11,986 | 0 to 12 K |
Mar 15 2019 | TCDA | Tricida, Inc. | Lockey Claire | Chief Dev. Officer ... | Buy | M | 0.80 | 11,986 | 9,589 | 11,986 | 0 to 12 K |
Mar 01 2019 | TCDA | Tricida, Inc. | COUFAL SANDRA I | Director | Sell | S | 23.04 | 2,000 | 46,080 | 17,725 | 19.7 K to 17.7 K (-10.14 %) |